Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
AssigneeThe William M. Yarbrough Foundation
InventorMichael E. Silver
Life of this patent
Estimating the term…
Abstract
A formulation, including: (a) a first medicament, wherein the first medicament includes an isothiocyanate functional compound/surfactant; and (b) a second medicament, wherein the second medicament includes an antineoplastic agent, such as a cytotoxic antineoplastic agent and/or a targeted antineoplastic agent.
Claims21
A method for treating a benign neoplasm, an in situ neoplasm, a malignant neoplasm, and/or a neoplasm of uncertain or unknown behavior in a patient, comprising the steps of:
- administering a medicament formulation to a patient having a benign neoplasm, an in situ neoplasm, a malignant neoplasm, and/or a neoplasm of uncertain or unknown behavior, wherein the medicament formulation comprises:
- a first medicament, wherein the first medicament comprises an isothiocyanate functional surfactant;
- and
- a second medicament, wherein the second medicament comprises an antineoplastic agent.
A method for treating a benign neoplasm, an in situ neoplasm, a malignant neoplasm, and/or a neoplasm of uncertain or unknown behavior in a patient, comprising the steps of:
- administering a medicament formulation to a patient having a benign neoplasm, an in situ neoplasm, a malignant neoplasm, and/or a neoplasm of uncertain or unknown behavior, wherein the medicament formulation comprises:
- a first medicament, wherein the first medicament comprises an isothiocyanate functional surfactant;
- and
- an optional second medicament, wherein the optional second medicament comprises an antineoplastic agent.
Dependencies are inferred from the claim text.